Literature DB >> 17140353

Antimicrobial resistance in tuberculosis: an international perspective.

Paul D van Helden1, Peter R Donald, Thomas C Victor, H Simon Schaaf, Eileen G Hoal, Gerhard Walzl, Robin M Warren.   

Abstract

Drug-resistant tuberculosis is a threat to tuberculosis control programs and community health. This growing problem mirrors the increasing incidence of tuberculosis in general. Public health problems include the absence of early diagnosis and effective treatment. The real need is to identify tuberculosis patients far earlier, particularly those with drug-resistant strains, and to begin appropriate therapy, which is of the shortest possible duration with minimal risk of acquiring further drug resistance or permitting further transmission. This article will address the epidemic of drug resistance and discuss some of the inherent difficulties in the treatment of drug-resistant tuberculosis. We highlight some of the controversies and new findings in this area, as well as future perspectives requiring more active interventions, in addition to new technology and developments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140353     DOI: 10.1586/14787210.4.5.759

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  7 in total

1.  CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Authors:  Steven M Truscott; Getahun Abate; Jeffrey D Price; Claudia Kemper; John P Atkinson; Daniel F Hoft
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

Review 2.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

Review 3.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

4.  Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.

Authors:  Alistair D Calver; Alecia A Falmer; Megan Murray; Odelia J Strauss; Elizabeth M Streicher; Madelene Hanekom; Thelma Liversage; Mothusi Masibi; Paul D van Helden; Robin M Warren; Thomas C Victor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

5.  Implementation of a national anti-tuberculosis drug resistance survey in Tanzania.

Authors:  Timothy M Chonde; Basra Doulla; Frank van Leth; Sayoki G M Mfinanga; Nyagosya Range; Fred Lwilla; Saidi M Mfaume; Armand van Deun; Matteo Zignol; Frank G Cobelens; Saidi M Egwaga
Journal:  BMC Public Health       Date:  2008-12-30       Impact factor: 3.295

6.  Identification of gene targets against dormant phase Mycobacterium tuberculosis infections.

Authors:  Dennis J Murphy; James R Brown
Journal:  BMC Infect Dis       Date:  2007-07-26       Impact factor: 3.090

7.  A mathematical study of a TB Model with treatment interruptions and two latent periods.

Authors:  Luju Liu; Yan Wang
Journal:  Comput Math Methods Med       Date:  2014-05-22       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.